EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Acute effects of intranasal esketamine application on thalamic structures in healthy individuals

Benjamin Spurny-Dworak, Thomas Liebe, Samantha Graf, Gregor Dörl, Peter Stöhrmann, Elisa Briem, Manfred Klöbl, Clemens Schmidt, Marie Spies, Rupert Lanzenberger iD

International Journal of Neuropsychopharmacology · 2025

DOI: 10.1093/ijnp/pyaf037 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Neuropsychopharmacology, 2025. Verfasst von Benjamin Spurny-Dworak und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Ketamine, Thalamus, Excitatory Amino Acid Antagonists. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: DFG Walter Benjamin-Stipendium, Austrian Academy of Sciences, MD PhD Excellence Program of the Medical University of Vienna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The N-methyl-D-aspartate receptor antagonist ketamine has found broad application in the field of psychiatry. Due to its rapid antidepressant and anti-suicidal properties, it is used as a treatment for major depressive disorder. Furthermore, ketamine evokes dissociative and psychotropic states, which allows the modeling of schizophrenic symptoms. The thalamus, a main target for ketamine’s actions, consists of different nuclei responsible for sensory gating, attention, and consciousness. Thus, we here examine the effects of intranasally applied ketamine on thalamic structures in healthy individuals in a cross-over placebo-controlled study.

Methods

Twenty-six subjects (14 female, mean age ± SD = 24.3 ± 3 years) underwent two magnetic resonance imaging scans on a 3T system immediately after receiving a subanesthetic dose of 56 mg esketamine (2x Spravato 28mg nasal sprays) or placebo in a cross-over study design. FreeSurfer was used for morphological analysis of the thalamus and its distinct nuclei based on derived T1-weighted MPRAGE images. Repeated measure analyses of covariance across the whole group, regardless of measurement order, and the subgroup, receiving placebo in the first scan, were performed for the thalamus and all its nuclei, for each hemisphere, separately. Post hoc tests on thalamic nuclei were done in an exploratory manner.

Results

We found a significant volume increase in the right thalamus (pcorr. = .048), the pulvinar anterior nucleus (p = .048), and the right mediodorsal lateral parvocellular (p = .034) after esketamine in the subsample receiving placebo application in the first scan.

Conclusion

Our results suggest rapid structural adaptations in right thalamic structures which serve as relay stations for the visual cortex. This emphasizes the thalamus’ role in visual perception after esketamine and its importance as a target to model schizophrenic symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KetamineThalamusExcitatory Amino Acid AntagonistsHumansFemaleMaleAdministration, IntranasalMagnetic Resonance ImagingCross-Over StudiesAdultYoung AdultDouble-Blind MethodHealthy Volunteers

Stichwörter der Autor:innen

MDDintranasalketamineschizophreniastructuralthalamus

Substanzen

KetamineEsketamineExcitatory Amino Acid Antagonists

Autor:innen und Institutionen

  • Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.
  • Comprehensive Center for Clinical Neurosciences and Mental Health (C3NMH), Medical University of Vienna, Vienna, Austria.
  • Department of Psychiatry and Psychotherapy, University of Jena, Jena, Germany.

ORCID-Profile: Rupert Lanzenberger

Förderung

  • DFG Walter Benjamin-Stipendium
  • Austrian Academy of Sciences
  • MD PhD Excellence Program of the Medical University of Vienna

Zitieren

APA

Spurny-Dworak, B., Liebe, T., Graf, S., Dörl, G., Stöhrmann, P., Briem, E., Klöbl, M., Schmidt, C., Spies, M., & Lanzenberger, R. (2025). Acute effects of intranasal esketamine application on thalamic structures in healthy individuals. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyaf037

Vancouver

Spurny-Dworak B, Liebe T, Graf S, Dörl G, Stöhrmann P, Briem E, et al. Acute effects of intranasal esketamine application on thalamic structures in healthy individuals. International Journal of Neuropsychopharmacology. 2025. doi:10.1093/ijnp/pyaf037

BibTeX
@article{SpurnyDworak2025,
  author = {Spurny-Dworak, Benjamin and Liebe, Thomas and Graf, Samantha and Dörl, Gregor and Stöhrmann, Peter and Briem, Elisa and Klöbl, Manfred and Schmidt, Clemens and Spies, Marie and Lanzenberger, Rupert},
  title = {Acute effects of intranasal esketamine application on thalamic structures in healthy individuals},
  journal = {International Journal of Neuropsychopharmacology},
  year = {2025},
  doi = {10.1093/ijnp/pyaf037}
}
Kostenlos starten →